Amerise Biosciences Enterprise Value (EV)

Amerise Biosciences Ltd Enterprise Value

The Amerise Biosciences Ltd Enterprise Value is a key financial metric used by investors to evaluate Amerise Biosciences Ltd's valuation, profitability, and overall financial performance. Tracking the Amerise Biosciences Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Amerise Biosciences Ltd (NSE: , BSE: 531681) is currently trading at ₹0.72, with a market capitalization of ₹47.57M. As a leading company in the Finance sector and Financial conglomerates industry, monitoring the Amerise Biosciences Ltd Enterprise Value is essential for fundamental analysis.

Amerise Biosciences Ltd Enterprise Value Current Value

The current Amerise Biosciences Ltd Enterprise Value stands at 0.

The Amerise Biosciences Ltd Enterprise Value remains stable, indicating consistent financial performance.

Amerise Biosciences Ltd Enterprise Value Historical Trend

The Amerise Biosciences Ltd Enterprise Value has shown the following historical trend:

The decline in Amerise Biosciences Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.

What Amerise Biosciences Ltd Enterprise Value Indicates for Investors

The Amerise Biosciences Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Amerise Biosciences Ltd.

Amerise Biosciences Ltd Enterprise Value Analysis Summary

The Amerise Biosciences Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Amerise Biosciences Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Amerise Biosciences Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.